Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.620
+0.090 (5.86%)
At close: Feb 9, 2026, 4:00 PM EST
1.620
0.00 (0.00%)
After-hours: Feb 9, 2026, 4:00 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $9.91 million as of February 9, 2026. Its market cap has decreased by -75.21% in one year.
Market Cap
9.91M
Enterprise Value
-638.67K
1-Year Change
-75.21%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $9.91M, a decrease of -98.43%. That is a compound annual growth rate of -57.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 9.42M | -7.25% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 9.90M |
| GridAI Technologies | 9.78M |
| Edesa Biotech | 9.33M |
| Evogene | 9.25M |
| NuCana | 9.24M |
| BioRestorative Therapies | 9.23M |
| Pulmatrix | 9.06M |
| SeaStar Medical Holding | 8.94M |